References
- US Renal Data SystemUSRDS 2006 Annual Data ReportBethesda, MDNational Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases2006
- NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality InitiativeAm J Kidney Dis1997304 Suppl 3S192S2409339151
- National Kidney FoundationK/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin TargetAm J Kidney Dis20075047153017720528
- RobertsonHTHaleyNRGuthrieMCardenasDEschbachJWAdamsonJWRecombinant erythropoietin improves exercise capacity in anemic hemodialysis patientsAm J Kidney Dis1990153253322321645
- PickettJLThebergeDCBrownWSSchweitzerSUNissensonARNormalizing hematocrit in dialysis patients improves brain functionAm J Kidney Dis19993361122113010352201
- FoleyRNParfreyPSHarnettJDKentGMMurrayDCBarrePEThe impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal diseaseAm J Kidney Dis19962853618712222
- HarrisDCHLawrenceSChampionJRLow dose erythropoietin in maintenance hemodialysis patients: improvement in quality of life and reduction in true cost of hemodialysisN Z Med J199121693700
- StevensMESummerfieldGPHallAACost benefits of low dose subcutaneous erythropoietin in patients with anemia of end stage renal diseaseBr Med J19923044744771547417
- PoweNRGriffithsRIWatsonAJEffect of recombinant erythropoietin on hospital admissions, readmissions, length of stay, and costs of dialysis patientsJ Am Soc Nephrol199447145514658161727
- CollinsAJLiSEbbenJMaJZManningWHematocrit levels and associated Medicare expendituresAm J Kidney Dis200036228229310922306
- CollinsAJLiSSt PeterWLDeath, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36% to 39%J Am Soc Nephrol2001122465247311675424
- IshaniAGuoHGilbertsonDTTime to target haemoglobin concentration (11 g/dl)–risk of hospitalization and mortality among incident dialysis patientsNephrol Dial Transplant2007222247225517597082
- HebertPLGeissLSTierneyEFEngelgauMMYawnBPMcBeanAMIdentifying persons with diabetes using Medicare claims dataAm J Med Qual199914627027710624032
- KlineRBPrinciples and practice of Structural Equation ModelingNew York, NYThe Guilford Press1998
- BartholomewDJKnottMLatent Variable Models and Factor Analysis2nd edNew York, NYOxford University Press1999
- Batista-FoguetJMCoendersGFerragudMAUsing structural equation models to evaluate the magnitude of measurement error in blood pressureStat Med200120152351236811468768
- DonaldsonGWGeneral linear contrasts on latent variable means: structural equation hypothesis tests for multivariate clinical trialsStat Med200322182893291712953287
- LeeSYSongXYBayesian analysis of structural equation models with dichotomous variablesStat Med200322193073308812973788
- EbbenJPGilbertsonDTFoleyRNCollinsAJHemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizationsClin J Am Soc Nephrol2006161205121017699349
- BesarabABoltonWKBrowneJKThe effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetinN Engl J Med199833995845909718377
- SinghAKSzczechLTangKLCorrection of anemia with epoetin alfa in chronic kidney diseaseN Engl J Med2006355202085209817108343